ABSTRACT A questionnaire survey of over 400 workers handling reactive dyes showed that over 15% had work related respiratory or nasal symptoms. Forty nine employees with symptoms were referred to chest clinics for detailed assessment attributed to reactive dyes. He had been advised by his trade union to consult his local Employment Medical Adviser. Two and a half years previously a colleague from the same dyehouse had been investigated for occupational asthma. Inhalation testing with a Levafix orange reactive dye provoked an asthmatic response; the dye was subsequently withdrawn from his place of work. This man's death at work with asthma gave urgency to this study.
tests to solutions of dyes and a positive radioallergosorbent test (RAST) to dyed paper discs suggested that the dyes were acting as haptens, provoking an IgE mediated hypersensitivity reaction. Subsequently Kalas and Runstukova found that eight of 106 textile workers exposed to reactive dyes had symptoms of occupational asthma.2
Our study followed up two separate incidents involving reactive dyes, one in Manchester and the other in Leicester. In Manchester two dyehouse operatives were brought to the attention of the Employment Medical Advisory Service by their trade union safety representative. They complained of recurrent severe nasal blocking which they attributed to Procion MX dye powders. In addition, both workers gave histories of exercise induced asthma. In Leicester a dyehouse employee presented with asthma which he Accepted 13 October 1986 (ej Crown copyright 1986. attributed to reactive dyes. He had been advised by his trade union to consult his local Employment Medical Adviser. Two and a half years previously a colleague from the same dyehouse had been investigated for occupational asthma. Inhalation testing with a Levafix orange reactive dye provoked an asthmatic response; the dye was subsequently withdrawn from his place of work. This man's death at work with asthma gave urgency to this study.
The first phase of the study was to identify, by means of a questionnaire administered by a physician, those dyehouse operatives with work related upper and lower respiratory tract symptoms. Symptomatic employees identified by the questionnaire were referred to one of two chest physicians who investigated the nature of their symptoms, their severity, relation with work, and the possible causative agents. The study included an estimate of the prevalence of specific IgE to dye-human serum albumin conjugates (dye-HSA) as a measure of immunological response in employees exposed to reactive dyes, and to relate this to symptoms, atopy, and smoking.
In the present paper we report the clinical and immunological findings on the employees referred to 534 Respiratory disease in dye workers the chest clinics and data on the population from which they were drawn. The study was not an epidemiological survey; the first phase was designed primarily to identify symptomatic workers for detailed clinical investigation. The criteria for selection of workers for the clinical study differed somewhat between the areas studied and therefore the descriptions of the two populations are presented separately.
Materials and methods

STUDY GROUPS
All the dyehouses in the Manchester and Leicester areas were identified from HM Factory Inspectorate's records. Each was contacted to determine whether reactive dyes were in use. In each factory using reactive dyes all workers who at the time of the study were exposed to dye powders were included. In Manchester workers who had been exposed to dyes in the past but were not now exposed were also invited to participate in the study. In Manchester 196 employees were identified in a total of 22 dyehouses and in Leicester 218 in 30 dyehouses.
JOB CATEGORY
Employees were grouped into four exposure groups depending on their exposure to dye powders.
Group 1-Employees exposed to dye powders for most of their working day-for instance, dye storemen and mixers and weighers.
Group 2-Employees exposed to dye powders as part of their job such as dyers.
Group 3-Employees regularly exposed to small quantities of dyes such as laboratory staff and supervisors who were exposed to dye powders intermittently.
Group 4-Employees exposed in the past to dyes but currently working in jobs without dye exposure.
QUESTIONNAIRE. INTERVIEW
Two employment medical advisers, one for each area, administered to each employee a questionnaire about symptoms, smoking habits, and occupational history. Lower respiratory symptoms were defined as attacks of wheezing, chest tightness, or difficulty in breathing and were considered potentially associated with the work environment if better or less frequent when away from work. Nasal symptoms were defined as an itchy, runny, or blocked nose but excluding colds, and eye symptoms such as irritation or watering of the eyes, but excluding colds. These were considered to be potentially associated with the work environment if they were better or less frequent when away from work. Blood conjugates showed that total IgE concentrations < 4000 KU/L did not affect the RAST percentage binding, except for one dye, Remazol Black B, which gave 0 5% binding at 750 KU/L.4 Sera were tested with a dye-HSA conjugate disc if the dye list supplied by the firm indicated that the employee was exposed to one or more of the dyes included on the disc. Sera from employees exposed to both a yellow and orange dye were tested with the yellow/orange disc No 9; those exposed to either yellow or orange were tested with either disc No 4 or No 5 as appropriate. The same procedure was followed with green and brown discs Nos 7, 8, and 10. Table 2 gives the number of RAST tests carried out with the disc types and the number of positives.
QUESTIONNAIRE AND SPECIFIC IgE DATA,
MANCHESTER
The questionnaire responses of the study group in Manchester are summarised in table 3. Twenty four employees reported work related lower respiratory symptoms with or without nasal symptoms and 29 work related nasal symptoms only. Forty four reported respiratory or nasal symptoms or both which did not improve during periods away from work. Comparison between those with work related symptoms and asymptomatic employees showed no difference in age, duration of employment in current job, smoking status, or exposure group. Specific IgE to dye-HSA conjugates, however, was twice as common in those with work related symptoms but this difference was not statistically significant. Comparison of specific IgE with exposure categories 1-3 showed that 22% (9/41) of the highest exposure group (group 1) had specific IgE compared with 4% (4/101) and 9-5% (4/42) in groups 2 and 3 respectively. The observation that nine of the 20 employees in group 4-that is, those who had handled dyes in the past but were currently working in jobs without dye exposure-had specific IgE to dye-HSA conjugates suggests that at least in some of these employees sensitisation to dyes may have been a contributory cause for their relocation. On the basis of their response to the questionnaire, 23 employees in this area were considered to have work related respiratory symptoms that warranted referral to a chest clinic.
LEICESTER
The questionnaire responses of the study group in Leicester are given in table 4. Ten employees reported work related lower respiratory symptoms with or without nasal symptoms and 11 nasal symptoms only: 22 reported lower respiratory or nasal symptoms or both which did not improve during periods away from work. Comparison between those with work related symptoms and asymptomatic employees showed no difference in age, duration of employment in current Job, smoking status, or exposure group.
Specific IgE to dye-HSA conjugates, however, was significantly more common in those with work related symptoms, 38% (8/21) compared with 8-3% (14/175) for the asymptomatic employees. On the basis of their response to the questionnaire, 36 employees were referred to a chest clinic; they were all those with lower respiratory symptoms whether or not this was related to exposure to dye (14 employees), those with nasal symptoms associated with dye exposure (11 employees), and those asymptomatic but RAST positive (11 employees).
CLINICAL ASSESSMENT OF EMPLOYEES REFERRED TO CHEST CLINICS
Of the 23 employees referred in Manchester, 22 attended the chest clinic and in Leicester 34 of the 36. In addition, two employees in Leicester were referred shortly after the asthmatic death as was another employee in Leicester who developed work'related respiratory symptoms four months after the survey. All the employees seen at the chest clinics were skin prick tested with dye-HSA conjugates 1-8 (see table I for list of dyes in each conjugate group) and common environmental allergens.
The 49 symptomatic workers were divided into four groups on the basis of the pattern of their clinical response (table 5). Twenty one had nasal or lower respiratory tract symptoms suggestive of a response caused by a specific allergic reaction to a reactive dye (group A, table 5). Eight had only nasal symptoms and four had lower respiratory symptoms, in some associated with nasal symptoms, that were immediate in onset and although of short (less than 30 minutes) duration, in some caused severe difficulty with breathing. These symptoms were distinguished by the specificity of the provoking factor (an identified reactive dye) from the similar "irritant" symptoms that were provoked by a variety of chemicals. In addition (table 7) . Nineteen (group B, table 5) of the 49 complained of symptoms suggestive of a non-specific "irritant" response of their eyes, nose, and lower respiratory tract provoked by a variety of the chemicals used in the dyehouses. These included hydrochloric acid vapour, sulphur dioxide evolved from heated sodium hydrosulphite, and several of the reactive dyes. Symptoms complained of varied in severity from itching and running of the nose to cough with chest tightness developing within minutes of exposure and lasting up to 30 minutes from exposure. These symptoms were distinguished from allergic symptoms by the lack of specificity in the exposures provoking them. Table 6 shows that these "irritant" reactions are strongly associated with atopic status and only weakly associated with specific IgE to dye-HSA conjugates.
Three other patients (group C, We were faced with an enormous range ofdyes, and for most the chemical structures are not published. RAST testing of each employee with each dye was not feasible, so we prepared dye-HSA conjugates of the most frequently used dyes and pooled those with the same basic colour to produce 10 pooled dye-HSA conjugate mixes that were used in a RAST screen. As a result we are less secure in the interpretation of the IgE data than when workers are exposed to a limited number of allergens, which may each be tested individually. The RAST screen, however, identified specific IgE in all the workers who were subsequently shown to have positive RASTs to conjugates of those dyes they identified as causing their symptoms. The RAST screen was positive for the majority, 17/21 (81%) of employees with dye related allergic symp-toms. None of the four RAST negative allergic employees gave a positive RAST when tested with individual dye-HSA conjugates; however, we still cannot be entirely certain that we have tested them with the relevant dye.
Many allergic employees responded to more than one dye-HSA conjugate, with nearly 50% showing immunological reactions, both by skin prick test and RAST to the yellow/orange dye-HSA conjugates, compared with only 25% responding to the green/ brown dye-HSA conjugates. This suggests that either the yellow/orange dyes are more immunogenic than the other dyes or they are dustier so that more is inhaled during their use. Since the cold reactive dyes react at lower temperatures, they would be expected to be more immunogenic, reacting more readily with protein in the lung. Anecdotal evidence from employees who have become sensitised bears this out, in that several implicated cold reactive dyes as causative agents.
The relations between the patterns of provoked respiratory symptoms, atopy, and specific IgE antibody to dye-HSA conjugates provides possible insight into the underlying mechanisms of the observed responses. Sixty eight per cent of those with irritant reactions and 86% of those with "allergic" reactions were atopic. It seems possible that the relatively high proportion of atopics among those experiencing irritant reactions reflects the increased bronchial responsiveness in atopics as compared with the non-atopic population. Atopy may also predispose to specific IgE antibody production to reactive dyes; specific IgE was identified in 81% of those with "allergic" symptoms but only 37% of those with irritant symptoms, suggesting that allergic symptoms may be the manifestation of a specific IgE mediated response to one or more reactive dyes.
At first sight our results appear to suggest that exclusion of atopic individuals would minimise the risk of sensitisation and respiratory disease. Atopy, 541 however, is a poor predictor of subsequent response to reactive dyes. Between a third and a half of working populations are atopic. Of our study group of 414, we can estimate that 150 to 200 atopic subjects would have to be excluded to prevent development of respiratory symptoms in 31 subjects. This policy would not have prevented the development of respiratory symptoms in the nine non-atopic subjects. Prevention of respiratory disease among dyehouse operatives will be achieved with better working practices and improved hygiene control to reduce the concentration of chemical vapour and dust from dye powders in the factory environment.
